Additionally, ZFPM2-AS1 can promote NSCLC progression via the miR-511-3p/AFF4 and miR-18b-5p/VMA21 pathways (Li et al., 2020; Xue et al., 2020), and enhance the malignancy of cervical cancer by sponging microRNA-511-3p (Dai et al., 2020). Here, ZFPM2 is linked to non-small cell lung carcinoma.